SCHEMBL30801192

SCHEMBL30801192

O=C(O)c1cc2c(ccn2-c2n[nH]c3ccccc23)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTNNB1 P35222 2/20 0.38
▸ WNT3A P56704 2/20 0.38
▸ MAP2K4 P45985 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ MAPKAPK3 Q16644 1/20 0.38
▸ MAPK6 Q16659 1/20 0.38
▸ MAPK10 P53779 4/20 0.36
▸ ITK Q08881 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ BTK Q06187 1/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ CCNA1 P78396 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801218 0.80 ITK (0.48) CTNNB1WNT3AMAP2K4MAPK1MAPKAPK3
SCHEMBL30801295 0.80 ITK (0.51) CTNNB1WNT3AMAP2K4MAPK1MAPKAPK3
SCHEMBL2880089 0.73 PRKD3 (0.42) MAPK10ITKRAB9ANPC1TP53
SCHEMBL30801175 0.69 GRM4 (0.41) ITKMAPTFLT3
SCHEMBL30801308 0.69 MAPK10 (0.55) MAP2K4MAPK6MAPK10ITKBTK
SCHEMBL16720663 0.67 KDM4E (0.36) CTNNB1WNT3AMAPK10ITKRAB9A
SCHEMBL30801205 0.67 SMO (0.40) MAP2K4MAPK6MAPK10ITKBTK
SCHEMBL20027771 0.65 MAP2K4 (0.43) CTNNB1WNT3AMAP2K4MAPK1MAPKAPK3
SCHEMBL6669514 0.65 FGFR1 (0.61) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL2610321 0.65 KCNH2 (0.47) MAPTRAB9ASMN1; SMN2HSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693502-A Compounds for inhibiting or degrading ITK, compositions comprising the same, methods of making the same, and methods of using the same 纽力克斯治疗公司 2024-03-12 — — CN disclosed
Send feedback